שימוש ב–3–(4–אמינו–1–אוקסו–3,1–דיהידרו–איזואינדול–2–איל)–פיפרידין–6,2–דיון להכנת תרופה לטיפול בלוקמיה מסוימות

• 收藏
• 分享

专利权人:

CELGENE CORPORATION

发明人:

申请号：

IL19043708

公开号：

IL190437A

申请日:

2008.03.25

申请国别(地区):

IL

年份:

2017

代理人:

摘要：

The invention relates to a methods of treating, preventing or managing leukemias. The methods encompass the administration of an immunomodulatory compound of the invention known as Revlimid(R) or lenalidomide. The invention further relates to methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods of the invention are also disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/